Changes in the electroretinogram resulting from discontinuation of vigabatrin in children

被引:36
作者
Westall, CA
Nobile, R
Morong, S
Buncic, JR
Logan, WJ
Panton, CM
机构
[1] Hosp Sick Children, Dept Ophthalmol, Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Dept Paediat, Div Neurol, Brain & Behav Programme, Toronto, ON M5S 1A1, Canada
基金
加拿大健康研究院;
关键词
ERG; pediatric; retinal toxicity; vigabatrin;
D O I
10.1023/B:DOOP.0000005339.23258.8f
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Electroretinograms (ERGs) have been recorded longitudinally in children before and during treatment with the antiepileptic drug vigabatrin for the past 3.5 years. Vigabatrin induced changes in ERG responses occur in children; the most dramatic changes occur in the oscillatory potentials. The purpose of this study was to identify changes in ERG responses associated with discontinuation of vigabatrin treatment. If vigabatrin-induced changes reverse after discontinuation of the drug we infer that the original change is not an indicator of toxicity. ERG data were analyzed from 17 children who discontinued vigabatrin therapy. The duration of treatment ranged from 5 to 52 months, the age for the first ERG ranged from 6 to 38 months (median 10 months). ERGs were tested using the standard protocol established by the International Society for Clinical Electrophysiology of Vision, with Burian-Allen bipolar contact-lens electrodes. In addition to standard responses we recorded photopic oscillatory potentials (OPs). During vigabatrin treatment OPs show a greater change than other ERG responses, with the early occurring wavelets from the photopic OPs showing the greatest change. With discontinuation of vigabatrin the amplitude of the early wavelets of the photopic OPs increased dramatically compared with amplitudes while taking the drug (paired t-test, p = 0.000075). The scotopic oscillatory potentials also show some recovery. Although changes in oscillatory potentials may occur with vigabatrin toxicity, a large change likely occurs with a non-toxic pharmacological effect of vigabatrin on GABAergic amacrine cells in the inner plexiform layer. Reduction of OPs in children on vigabatrin may not be related to toxicity.
引用
收藏
页码:299 / 309
页数:11
相关论文
共 45 条
[1]   Outer retinal dysfunction in patients treated with vigabatrin [J].
Arndt, CF ;
Derambure, P ;
Defoort-Dhellemmes, S ;
Hache, JC .
NEUROLOGY, 1999, 52 (06) :1201-1205
[2]   Visual field constriction and electrophysiological changes associated with vigabatrin [J].
Besch D. ;
Kurtenbach A. ;
Apfelstedt-Sylla E. ;
Sadowski B. ;
Dennig D. ;
Asenbauer C. ;
Zrenner E. ;
Schiefer U. .
Documenta Ophthalmologica, 2002, 104 (2) :151-170
[3]   The effects of vigabatrin on electrophysiology and visual fields in epileptics: A controlled study with a discussion of possible mechanisms [J].
Comaish I.F. ;
Gorman C. ;
Brimlow G.M. ;
Barber C. ;
Orr G.M. ;
Galloway N.R. .
Documenta Ophthalmologica, 2002, 104 (2) :195-212
[4]   Vigabatrin effect on inner retinal function [J].
Coupland, SG ;
Zackon, DH ;
Leonard, BC ;
Ross, TM .
OPHTHALMOLOGY, 2001, 108 (08) :1493-1496
[5]   Symptomatic and asymptomatic visual loss in patients taking vigabatrin [J].
Daneshvar, H ;
Racette, L ;
Coupland, SG ;
Kertes, PJ ;
Guberman, A ;
Zackon, D .
OPHTHALMOLOGY, 1999, 106 (09) :1792-1798
[6]   Severe persistent visual field constriction associated with vigabatrin [J].
Eke, T ;
Talbot, JF ;
Lawden, MC .
BRITISH MEDICAL JOURNAL, 1997, 314 (7075) :180-181
[7]   Randomized trial of vigabatrin in patients with infantile spasms [J].
Elterman, RD ;
Shields, WD ;
Mansfield, KA ;
Nakagawa, J .
NEUROLOGY, 2001, 57 (08) :1416-1421
[8]   VIGABATRIN TREATMENT IN CHILDREN [J].
FOIS, A ;
BUONI, S ;
DIBARTOLO, RM ;
DIMARCO, V ;
MOSTARDINI, R .
CHILDS NERVOUS SYSTEM, 1994, 10 (04) :244-248
[9]   Electro-ophthalmological recovery after withdrawal from vigabatrin [J].
Graniewski-Wijnands H.S. ;
Van der Torren K. .
Documenta Ophthalmologica, 2002, 104 (2) :189-194
[10]  
Gross-Tsur V, 2000, ANN NEUROL, V48, P60, DOI 10.1002/1531-8249(200007)48:1<60::AID-ANA9>3.0.CO